Application 060593
- Type
- ANDA
- Sponsor
- PURDUE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SEROMYCIN | CYCLOSERINE | CAPSULE;ORAL | 250MG | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 13845-1200 | SEROMYCIN | CYCLOSERINE | Parsolex Gmp Center, Inc. | ANDA | Current |
| 13845-1200 | SEROMYCIN | CYCLOSERINE | Purdue GMP Center LLC dba The Chao Center | ANDA | Current |
| 13845-1201 | CYCLOSERINE | CYCLOSERINE | Parsolex Gmp Center, Inc. | ANDA | Current |
| 13845-1201 | CYCLOSERINE | CYCLOSERINE | Purdue GMP Center LLC dba The Chao Center | ANDA | Current |
| 13845-1202 | Cycloserine | Cycloserine | Purdue GMP Center LLC | ANDA | Current |
| 13845-1202 | Cycloserine | Cycloserine | Parsolex Gmp Center, Inc. | ANDA | Current |
| 13845-1203 | Seromycin | CycloSERINE | Parsolex Gmp Center, Inc. | ANDA | Current |